Table 2.
Visual acuity at the final follow-up by diagnosis
| Diagnosis | ≥20/40 No (%) |
20/50–20/200 No (%) |
<20/200 No (%) |
Total no of patients | P-value |
|---|---|---|---|---|---|
| Toxoplasma | 10 (71.4) | 2 (14.3) | 2 (14.3) | 14 | 0.006* |
| Fungal endophthalmitis | 0 (0) | 0 (0) | 3 (100) | 3 | 0.540 |
| Tuberculosis | 1 (100) | 0 (0) | 0 (0) | 1 | 0.724 |
| Syphilis | 1 (100) | 0 (0) | 0 (0) | 1 | 0.724 |
| Fungal sclerokeratitis s/p PK | 0 (0) | 0 (0) | 1 (100) | 1 | 0.479 |
| Herpetic anterior uveitis (HSV) | 7 (35.0) | 9 (45.0) | 4 (20.0) | 20 | 0.874 |
| Herpetic anterior uveitis (HZO) | 15 (88.2) | 1 (5.9) | 1 (5.9) | 17 | <0.001* |
| Acute retinal necrosis (CMV) | 1 (25.0) | 1 (25.0) | 2 (50.0) | 4 | 0.504 |
| Acute retinal necrosis** | 1 (14.3) | 2 (28.6) | 4 (57.1) | 7 | 0.504 |
| Acute retinal necrosis (VZV) | 1 (33.3) | 0 (0) | 2 (66.7) | 3 | 0.724 |
| Herpetic panuveitis (HZO) | 0 (0) | 0 (0) | 1 (100) | 1 | 0.480 |
| CMV retinitis | 2 (40.0) | 1 (20.0) | 2 (40.0) | 5 | 0.752 |
| Total | 39 (50.6) | 16 (20.8) | 22 (28.6) | 77 |
Notes:
*
Statistically significant at 5% level.
**
No virus isolated.
Abbreviations: PK, penetrating keratoplasty; HSV, herpes simplex virus; HZO, herpes zoster ophthalmicus; CMV, cytomegalovirus; VZV, varicella-zoster virus.